A Phase III Comparison of Fludarabine Phosphate (NSC #312887) vs Chlorambucil vs Fludarabine Phosphate Plus Chlorambucil in Previously Untreated B-cell Chronic Lymphocytic Leukemia

Long-term survival analysis ofthe North American Intergroup study C9011 comparing fludarabine (f) and chlorambucil (c) in previously untreated patients with chronic lymphocytic leukemia (CLL)

K Rai;BL Peterson;FR Appelbaum;M Tallman;A Belch;VA Morrison;RA Larson Blood 114:abstr #536 (ASH 2009 Annual Meeting, oral presentation)

Addition of rituximab to fludarabine may prolong progression-free survival and overall survival in patients with previously untreated chronic lymphocytic leukemia: an updated retrospective comparatiave analysis of CALGB 9712 and CALGB 9011

JC Byrd;K Rai;BL Peterson;FR Appelbaum;VA Morrison;JE Kolitz;L Shepherd;JD Hines;CA Schiffer;RA Larson Blood 105(1):49-53

Prognostic significance of CD38 and CD20 expression as assessed by quantitative flow cytometry in chronic lymphocytic leukaemia

ED Hsi;KJ Kopecky;FR Appelbaum;DH Boldt;T Frey;M Loftus;MA Hussein British Journal of Haematology 120:1017-1025

Analysis of age, estimated creatinine clearance and pretreatment hematologic parameters as predictors of fludarabine toxicity in patients treated for chronic lymphocytic leukemia: a CALGB (9011) coordinated Intergroup study

RE Martell;BL Peterson;HJ Cohen;WP Petros;KR Rai;VA Morrison;L Elias;L Shepherd;J Hines;RA Larson;CA Schiffer;HI Hurwitz Cancer Chemotherapy and Pharmacology 50:37-45

Impact of therapy with chlorambucil, fludarabine, or fludarabine plus chlorambucil on infections in patients with chronic lymphocytic leukemia: Intergroup Study Cancer and Leukemia Group B 9011

VA Morrison;KR Rai;BL Peterson;JE Kolitz;L Elias;FR Appelbaum;JD Hines;L Shepherd;RE Martell;RA Larson;CA Schiffer Journal of Clinical Oncology 19(16):3611-3621

Prognostic significance of CD38 and CD20 expression in chronic lymphocytic leukemia (CLL) as assessed by quantitative flow cytometry.

E Hsi;KJ Kopecky;FR Appelbaum;DH Boldt;M Loftus;T Frey;MA Hussein Blood 98(11):357a(#1504)

Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia

KR Rai;BL Peterson;FR Appelbaum;JE Kolitz;L Elias;L Shepherd;JD Hines;GA Threatte;RA Larson;BD Cheson;CA Schiffer New England Journal of Medicine 343(24):1750-1757

Therapy-related myelodysplastic syndrome (T-MDS) or acute myeloid leukemia (T-AML) in patients with chronic lymphocytic leukemia (CLL) treated with chlorambucil (C), fludarabine (F), or fludarabine + chlorambucil (F + C): An intergroup study (Cancer and Leukemia Group B (CALBG) 9011)

VA Morrison;KR Rai;B Peterson;JE Kolitz;L Elias;JD Hines;L Shepherd;RA Larson;CA Shiffer Proc of the American Society of Clinical Oncology 18:9a(#29)

Transformation to Richter's syndrome or prolymphocytic leukemia (PLL), and other second hematologic malignancies in patients iwth chronic lymphocytic leukemia (CLL): an Intergroup study (CALGB 9011)

VA Morrison;KR Rai;BL Peterson;JE Kolitz;L Elias;JD Hines;L Shepherd;RA Larson;CA Schiffer Blood 94(10)Suppl.1:539a(#2410)part_1_of_2

A randomized comparison of fludarabine and chlorambucil for patients with previously untreated chronic lymphocytic leukemia. A CALGB, SWOG, CTG/NCI-C and ECOG Inter-group study.

KR Rai;B Peterson;L Elias;L Shepherd;J Hines;D Nelson;B Cheson;J Kolitz;CA Schiffer Blood 88:141a(#552)

Fludarabine induces a high complete remission rate in previously untreated patients with active chronic lymphocytic leukemia (CLL). A randomized inter-group study.

KR Rai;B Peterson;J Kolitz;L Elias;L Shepherd;J Hines;B Cheson;C Schiffer Blood 86(10)(Suppl.1)(#2414):607a

The detection of trisomy 12 in chronic lymphocytic leukemia by fluorescence in situ hybridization.

PA Scalamogna;KS Theil American Journal of Clinical Pathology 101(3):377(#8)